GREAT POINT PARTNERS LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share (VTGN)

Filing Manager
GREAT POINT PARTNERS LLC
Reporting Manager
Great Point Partners, LLC
Security
Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
VTGN
Shares outstanding
41,532,000 shares
Disclosed Ownership
2,055,834 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:16:18 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Great Point Partners, LLC 5% 2,055,834 0 2,055,834 /s/ Dr. Jeffrey R. Jay, M.D Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Dr. Jeffrey R. Jay, M.D. 5% 2,055,834 0 2,055,834 /s/ Dr. Jeffrey R. Jay, M.D Dr. Jeffrey R. Jay, M.D
Ms. Lillian Nordahl 5% 2,055,834 0 2,055,834 /s/ Ms. Lillian Nordahl Ms. Lillian Nordahl